Translational research: A patient-centered approach to bridge the valley of death

Anish Thomas1, Parth Desai1, Nobuyuki Takahashi2

  • 1Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Cancer Cell
|May 13, 2022
PubMed

Insights

Translational cancer research must shift focus from animal models to human patients. Understanding individual tumor variability is key to predicting patient outcomes and advancing cancer treatments.

Area of Science:

  • Oncology
  • Translational Research
  • Cancer Biology

Background:

  • Animal models are crucial in cancer research for drug testing and biological discovery.
  • Despite extensive use, animal models have not led to expected treatment advances.
  • A model-centric approach may limit the translation of findings to human patients.

Purpose of the Study:

  • To propose a shift in translational research focus from animal models to human patients.
  • To emphasize understanding inter-patient tumor variability for personalized treatment prediction.
  • To generate more human-relevant hypotheses in cancer research.

Main Methods:

  • This study is a conceptual proposal and does not involve experimental methods.
  • It advocates for a paradigm shift in research strategy.
  • Focuses on analyzing patient data and clinical outcomes.

Main Results:

  • The current model-centric approach has limitations in predicting human cancer response.
  • Patient-level variability in tumor response and outcomes is significant.
  • A human-centric approach is proposed to improve translational success.

Conclusions:

  • Translational cancer research should prioritize human patient data over animal models.
  • Understanding individual patient variability is essential for predicting treatment efficacy.
  • Shifting focus to patients will yield more relevant discoveries and treatment advances.

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.9K
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.4K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
125
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K